Features | Partner Sites | Information | LinkXpress
Sign In
SEEGENE
AB Sciex
FOCUS DIAGNOSTICS, INC.

Portable Smartphone Microscope Combination Created

By Labmedica International staff writers
Posted on 03 Oct 2013
Image: Screen of the Nokia cell phone showing the fluorescence image of 1 μm diameter green fluorescent beads (Photo courtesy of University of California, Los Angeles).
Image: Screen of the Nokia cell phone showing the fluorescence image of 1 μm diameter green fluorescent beads (Photo courtesy of University of California, Los Angeles).
A novel smartphone microscope adjunct has been created that can detect very small objects including particles that measure approximately 150 nm to 300 nm.

The portable smartphone attachment can be used to detect viruses and bacteria, eliminating the need for expensive or bulky microscopes and laboratory equipment and only weighs 186 grams.

Bioengineers at the University of California (Los Angeles, CA, USA) attached the device directly to the camera of a smartphone, and described it as a "fluorescent microscope." It was created using a three-dimensional (3D) printer and contains a color filter, an external lens, and a laser diode. The attachment works by illuminating fluid or solid samples at an angle of approximately 75 degrees using the diode. By illuminating the samples at this angle, the scientists say it avoids detecting scattered light that could interfere with the fluorescent image.

This field-portable fluorescent imager on the cell phone involves a compact laser-diode-based excitation at 450 nm that illuminates the sample plane at a high incidence angle, a long-pass (LP) thin-film interference filter, an external low numerical aperture (NA lens), and a coarse mechanical translation stage for focusing and depth adjustment. The 3D optomechanical attachment to the PureView 808 cell phone (Nokia; Espoo, Finland) was designed using Inventor software (Autodesk; San Rafael, CA, USA) and built by a 3D printer (Dimension Elite; Edina, MN, USA).

The device was able to detect single human Cytomegalovirus (HCMV) particles, a virus that can cause birth defects including deafness and brain damage. A single HCMV particle measures approximately 150 nm to 300 nm and the device detected the particles clearly. The device was able to detect nanoparticles, which were marked fluorescent polystyrene beads created especially for the test that measured between 90 nm to100 nm.

The authors concluded that given its high sensitivity and field-portability, the cell-phone-based fluorescence-imaging platform could be useful for specific imaging of various fluorescently labeled specimens such as bacteria and viruses in field settings. Therefore, it holds significant promise for various point-of-care applications such as viral load measurements or other biomedical tests conducted in remote or resource-limited environments. The study was published on September 9, 2013, in the journal ACS Nano.

Related Links:

University of California
Nokia
Autodesk



GREINER-BIO-ONE
PURITAN MEDICAL
ADVANCED INSTRUMENTS
BioConferenceLive

Channels

Genetic Tests

view channel

Testing for Atypical Hemolytic Uremic Syndrome Goes NexGen

A patent pending genomic technique that rapidly sequences 12 genes associated with complement-mediated atypical hemolytic uremic syndrome (aHUS) is now being used to diagnose this rare disorder. Atypical hemolytic uremic syndrome (aHUS) is a very rare, life-threatening, progressive disease that frequently has a genetic component.... Read more

Hematology

view channel

Blood Donations Screened for Viruses Using Multiplex Assay

A global healthcare company was chosen to partner the Japanese Red Cross (JRC; Tokyo, Japan) for nucleic acid screening of the nation's blood supply. Under the terms of the 7-year agreement, the healthcare company, Grifols (Barcelona, Spain) will provide the JRC with its newest automation platform, the Procleix Panther... Read more

Pathology

view channel

Gene Profile Predicts Risk of Bladder Cancer Recurrence

A genomic study has pinpointed several markers that identify bladder cancer patients at risk of recurrence and that may be indicators of overall survival status. Nearly half of patients with bladder cancer experience recurrences, so reliable predictors of this recurrent phenotype are needed to guide surveillance and treatment.... Read more

Industry News

view channel

Roche Acquires IQuum, Strengthens Diagnostics Offerings with Unique System

The acquisition by Roche (Basel, Switzerland) of IQuum, Inc. (Marlborough, MA, USA) will enable Roche to more quickly enter the point-of-care (POC) segment of molecular diagnostics with products based on IQuum proprietary lab-in-tube technology. The technology underlies a novel biological sample testing platform that enables... Read more
 

Events

26 Apr 2014 - 30 Apr 2014
Copyright © 2000-2014 Globetech Media. All rights reserved.